No abstract available
MeSH terms
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20 / immunology*
-
Antigens, CD20 / therapeutic use
-
Antineoplastic Agents / immunology
-
Antineoplastic Agents / therapeutic use*
-
Child, Preschool
-
Fatal Outcome
-
Humans
-
Liver Transplantation / adverse effects*
-
Lymphoproliferative Disorders / drug therapy*
-
Lymphoproliferative Disorders / etiology*
-
Lymphoproliferative Disorders / immunology
-
Male
-
Risk Factors
-
Rituximab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20
-
Antineoplastic Agents
-
Rituximab